Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

被引：0
|
作者：
Meredith Hoog
Juan M. Maldonado
Ruth Wangia-Dixon
Rachel Halpern
Erin Buysman
Garrett W. Gremel
Ahong Huang
Manige Konig
机构：
[1] Eli Lilly and Company,
[2] Lilly Corporate Center,undefined
[3] Eli Lilly Export S.A.,undefined
[4] Optum Inc.,undefined
[5] Tigermed-BDM,undefined
来源：
Diabetes Therapy | 2024年 / 15卷
关键词：
Dulaglutide; Glycated hemoglobin; Glucagon-like peptide-1 receptor; Hispanic/Latino; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：855 / 867
页数：12
相关论文
共 50 条
  • [41] Impact of Initiating Insulin Glargine Disposable Pen Versus Vial/Syringe on Real-World Glycemic Outcomes and Persistence Among Patients with Type 2 Diabetes Mellitus in a Large Managed Care Plan: A Claims Database Analysis
    Xie, Lin
    Zhou, Steve
    Pinsky, Brett W.
    Buysman, Erin K.
    Baser, Onur
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (09) : 567 - 575
  • [42] Real-world characteristics of patients with type 2 diabetes on basal insulin initiating add-on GLP-1 analogue therapy
    Dalal, M. R.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    DiGenio, A.
    DIABETOLOGIA, 2012, 55 : S403 - S404
  • [43] PREDICTORS AND CLINICAL OUTCOMES OF TREATMENT INTENSIFICATION IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN IN A REAL-WORLD SETTING
    Kallenbach, Lee
    Shui, Amy M.
    Cheng, Wendy Y.
    Fan, Tao
    Hu, Wenli
    Zichlin, Miriam L.
    Duh, Mei Sheng
    Ye, Fen
    Levin, Philip A.
    ENDOCRINE PRACTICE, 2018, 24 (09) : 805 - 814
  • [44] Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide versus DPP-4is in a US real-world setting
    Lv, Lei
    Brady, Brenna L.
    Xie, Lin
    Guevarra, Mico
    Turchin, Alexander
    PRIMARY CARE DIABETES, 2024, 18 (05) : 511 - 517
  • [45] Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
    Bellido, Diego
    Abellan, Pablo
    Palomar, Jose Manuel Ruiz
    Sintes, Rogelio Alvarez
    Nubiolae, Andreu
    Bellido, Virginia
    Romero, Gracia
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 89 : 37 - 42
  • [46] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [47] Progression of Position of Basal Insulin in the Treatment of Type 2 Diabetes-A Real-World Analysis
    Schapiro, David
    Meeks, Alexandra
    Liu, Dongju
    Gelsey, Felicia
    Juneja, Rattan
    Perez-Nieves, Magaly
    Huang, Ahong
    DIABETES, 2022, 71
  • [48] Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study
    Borgharkar, Surendra S.
    Das, Soma S.
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [49] Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real-world observational study
    Shabnam, Sharmin
    Abner, Sophia
    Gillies, Clare L.
    Davies, Melanie J.
    Dex, Terry
    Khunti, Kamlesh
    Webb, David R.
    Zaccardi, Francesco
    Seidu, Samuel
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 512 - 523
  • [50] Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs
    Baser, Onur
    Tangirala, Krishna
    Wei, Wenhui
    Xie, Lin
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 497 - 505
12345